First-Line Lenvima Plus Keytruda Misses Mark in Endometrial Cancer
For patients with advanced or recurrent endometrial cancer, first-line Lenvima plus Keytruda didn’t significantly improve outcomes versus chemotherapy.
For patients with advanced or recurrent endometrial cancer, first-line Lenvima plus Keytruda didn’t significantly improve outcomes versus chemotherapy.
A clinical trial manager emphasizes the importance of a phased approach to educating patients about complex protocols and potential side effects.
The targeted therapy appeared to be safe and effective in treating patients with KRAS G12C mutated pancreatic cancer, according to results from a recent study.
When I recognize my frustration and dissapointment with the test results for my chronic lymphocytic leukemia, I find comfort in listening to music.
The proportion of patients who have been diagnosed with cancer at an early stage in England is at its highest ever level
Read about the results of a RCN Northern Ireland consultation on the 2024-25 pay offer for nurses and other Health and Social Care staff.
Information, Tools and Support in Key Therapeutic Areas The quality care you provide to your patients stems from your dedication to treating them as a…
Read about the announcement of the theme for 2025’s International Nurses Day, which will focus on nurse wellbeing.
From the death of folk music star Peter Yarrow of Peter, Paul and Mary to good news from broadcasting legend Dick Vitale, here is this…
Read about why senior Conservative MP, Sir David Davis, has called for a retrial of convicted baby serial killer Lucy Letby.
A pioneering training pathway for GPNs is ‘driving change’ and helping to develop a ‘national culture’ for the training